435 related articles for article (PubMed ID: 32883226)
1. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
[TBL] [Abstract][Full Text] [Related]
2. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia.
Guo C; Ju QQ; Zhang CX; Gong M; Li ZL; Gao YY
BMC Cancer; 2020 Jun; 20(1):586. PubMed ID: 32571260
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients.
Tsai CH; Yao CY; Tien FM; Tang JL; Kuo YY; Chiu YC; Lin CC; Tseng MH; Peng YL; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF
EBioMedicine; 2019 Feb; 40():240-250. PubMed ID: 30662003
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
6. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
[TBL] [Abstract][Full Text] [Related]
7. Prediction of competing endogenous RNA coexpression network as prognostic markers in AML.
Wang JD; Zhou HS; Tu XX; He Y; Liu QF; Liu Q; Long ZJ
Aging (Albany NY); 2019 May; 11(10):3333-3347. PubMed ID: 31164492
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
9. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia.
Zeng H; Wu H; Yan M; Tang L; Guo X; Zhao X
Leuk Res; 2020 Jan; 88():106261. PubMed ID: 31739140
[TBL] [Abstract][Full Text] [Related]
11. Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
Yin X; Huang S; Xu A; Fan F; Chen L; Sun C; Hu Y
J Cell Biochem; 2020 Feb; 121(2):1563-1574. PubMed ID: 31535409
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA SNHG5 is up-regulated and serves as a potential prognostic biomarker in acute myeloid leukemia.
Li J; Sun CK
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3342-3347. PubMed ID: 29917184
[TBL] [Abstract][Full Text] [Related]
13. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
[TBL] [Abstract][Full Text] [Related]
14. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia.
Pan JQ; Zhang YQ; Wang JH; Xu P; Wang W
Int J Mol Med; 2017 Mar; 39(3):663-671. PubMed ID: 28204819
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer.
Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C
J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
[TBL] [Abstract][Full Text] [Related]
17. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
Xu Y; Chen J; Yang Z; Xu L
Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive DNA Methylation-transcriptome Profiles Association Analysis During the Treatment of Acute Myelocytic Leukemia.
Wu J; Song MZ; Deng LJ; Ye QL
Curr Pharm Des; 2021; 27(24):2817-2826. PubMed ID: 34082677
[TBL] [Abstract][Full Text] [Related]
20. A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
Lai Y; Sheng L; Wang J; Zhou M; OuYang G
Technol Cancer Res Treat; 2021; 20():15330338211004933. PubMed ID: 33784904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]